THE DARK REPORT
21806 Briarcliff Dr.
Spicewood, Texas 78669
FOR IMMEDIATE RELEASE
Media Contact: Ron Martin
AUSTIN, Texas (February 8, 2016) – As molecular technology and personalized medicine increasingly becomes the default position for clinical diagnostics laboratories, these modalities place significant demands on laboratory information systems. Although hospitals and healthcare institutions often focus on an electronic medical records system that includes a laboratory information system (LIS), those LIS’s do not typically have the functionality needed to handle current molecular testing needs, or needs expected in the near future.
“It is important that clinical diagnostics laboratories do have a capable system to handle molecular testing needs,” states Robert L. Michel, Editor-In-Chief of The Dark Report. “Pathology’s forward thinkers define molecular diagnostics and genetic testing as both the future of pathology and the #1 opportunity to add clinical value while earning appropriate reimbursement. But for pathologists to realize this potential and convert it into reality, they must have the right tools in place, including the ability to collect, store, retrieve, analyze, and report the data from molecular assays and genetic tests.”
Addressing the important topic of Molecular Information Management Systems (MIMS) is a recently published white paper from The Dark Report, entitled “Molecular Information Management Systems (MIMS): Pathologists are Using MIMS to Revolutionize Personalized and Predictive Medicine.” Published by The Dark Report and Dark Daily, it is available free to laboratory professionals as a PDF download.
This white paper discusses the trends in increasing use of genetic and molecular testing, the growth of big data in healthcare, and the challenges facing laboratories in handling the complexities of personalized medicine. It also outlines considerations when purchasing a MIMS, and challenges for MIMS and other HIT vendors in terms of compatibility between various HIT technologies. It provides a detailed discussion regarding:
- An overview of the current state of the MIMS industry
- What a MIMS is and what a MIMS is not
- What a pathology lab needs to do to acquire and use a MIMS to advance patient care and increase revenue
- Smart ways to purchase MIMS and get the best ROI
- How to evaluate key factors for calculating ROI on MIMS
Personalized medicine and predictive medicine have become a reality. As a result, the need for a molecular information management system will become increasingly important; specifically one that can handle the complex workflows of various molecular platforms a\nd modalities, and accommodate the large data volume, digital imaging and complex reporting needs that personalized medicine will require. To download “Molecular Information Management Systems (MIMS): Pathologists are Using MIMS to Revolutionize Personalized and Predictive Medicine,” click here. This is a free publication and part of the Dark Daily Resource Center, comprised of a growing library of white papers and other information resources tailored specifically to the needs of laboratory administrators, lab managers, pathologists, and lab industry consultants.
About THE DARK REPORT
Established in 1995, THE DARK REPORT is the leading source of exclusive business intelligence for laboratory CEOs, COOs, CFOs, Pathologists and Senior industry executives. It is widely read by leaders in laboratory medicine and diagnostics. The Dark Report produces the famous Executive War College on Laboratory and Pathology Management every spring, which showcases innovations by the nation’s and globe’s leading laboratory organizations. Dark Daily is an Internet-based e-briefing intelligence service, read worldwide by thought leaders in laboratory and pathology management. Other well-known conferences conducted by THE DARK REPORT are Lab Quality Confab (on the use of Lean and Six Sigma methods in labs and hospitals) and Molecular Summit (on the integration of in vivo and in vitro diagnostics). THE DARK REPORT co-produces Frontiers in Laboratory Medicine annually in the United Kingdom; Executive Edge bi-annually in Canada; and The Business of Pathology bi-annually in Australia.